Preemptive therapy for the prevention of cytomegalovirus disease following heart transplantation directed by PP65 antigenemia

By Villa M.   Lage E.   Ballesteros S.   Canas E.   Sanchez M.   Ordonez A.   Borrego J.M.   Hinojosa R.   Cisneros J.M.  

Transplantation Proceedings, Vol. 35, Iss. 2, 2003-03 ,pp. : 732-734

Elsevier

Access to resources Recommend Favorite

Cytomegalovirus antigenemia and renal function post-kidney-transplantation

By Schroeder R.   Mesko J.   Santos A.   Keitel E.   Bittar A.   Garcia V.   Neumann J.  

Transplantation Proceedings, Vol. 31, Iss. 7, 1999-11 ,pp. : 3027-3028

Elsevier

Access to resources Recommend Favorite

Use of cytomegalovirus antigenemia as a marker for preemptive treatment

By Guirado L.   Herreros M.A.   Munoz J.M.   Rabella N.   Facundo C.   Agraz I.   Daz M.   Diaz J.M.   Duran F.   Sola R.  

Transplantation Proceedings, Vol. 34, Iss. 1, 2002-02 ,pp. : 67-68

Elsevier

Access to resources Recommend Favorite

Usefulness of finger thermography to assess cyclosporine toxicity after heart transplantation

By Doutreleau S.   Gautherie M.   Lonsdorfer E.   Rouyer O.   Epailly E.   Eisenmann B.   Piquard F.   Geny B.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3318-3319

Elsevier

Access to resources Recommend Favorite

Detection of Human Cytomegalovirus in Renal Transplantation: Comparison of Four Diagnostic Methods: DNA In Sera by Polymerase Chain Reaction (PCR), DNA in Leukocyte by PCR, pp65 Leukocytic Antigenemia, and Viremia

By Eckart P.   Brouard J.   Vabret A.   Freymuth F.   Guillot M.   Ryckelynck J.   Hurault de Ligny B.  

Transplantation Proceedings, Vol. 29, Iss. 5, 1997-08 ,pp. : 2387-2389

Elsevier

Access to resources Recommend Favorite